Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients After Argus II Implantation: An International Study

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 01, 2018
Source ID
10.1016/j.ajo.2018.06.012

Entities

People

  • Albert J. Augustin
  • Aleksandra Rachitskaya
  • Alex Yuan
  • Allen C. Ho
  • Byron L. Lam
  • Catherine Hoeppner
  • David G. Birch
  • David N. Zacks
  • Gislin Dagnelie
  • Gregg T. Kokame
  • Hossein Ameri
  • J Fernando Arevalo
  • James T. Handa
  • James Weiland
  • Janet L. Davis
  • Jennifer I. Lim
  • Jiong Yan
  • K. Thiran Jayasundera
  • Lejla Vajzovic
  • Lisa Olmos De Koo
  • Mark S Humayun
  • Naresh Mandava
  • Natalia F. Callaway
  • Ninel Z. Gregori
  • Paul Hahn
  • Peter Szurman
  • Peter Wiedemann
  • Raymond Iezzi Jr.
  • Salvatore Grisanti
  • Sandra R. Montezuma
  • Suber S. Huang
  • William Feuer

Organizations

  • Allergan, Inc.
  • American Macular Degeneration Foundation
  • Applied Genetic Technologies Corporation
  • Astellas Pharma (United States)
  • BrightFocus Foundation
  • Foundation Fighting Blindness
  • Hoffmann-La Roche
  • Johnson & Johnson
  • Knights Templar Eye Foundation
  • National Eye Institute
  • National Institutes of Health
  • Novartis
  • Regeneron Pharmaceuticals
  • Roche (United States)
  • Sanofi-Aventis
  • Shire plc
  • United States Department of Defense